
201 - 500 employees
Founded 2013
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Travere Therapeutics is a biopharmaceutical company committed to identifying, developing, and delivering life-changing therapies for people living with rare diseases, particularly those related to rare kidney and metabolic disorders. The company has a strong focus on advancing science in these fields, with a pipeline that includes treatments for conditions such as IgA nephropathy and focal segmental glomerulosclerosis. With the full U. S. FDA approval of its non-immunosuppressive treatment for IgA nephropathy, Travere Therapeutics continues to set new standards of care. The company collaborates with the rare kidney disease community, including patient advocacy organizations and clinical trial investigators, to bring hope to patients with these serious conditions.
🕒 April 3
Improve your chances of getting an interview by checking your resume score before you apply.

201 - 500 employees
Founded 2013
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Travere Therapeutics is a biopharmaceutical company committed to identifying, developing, and delivering life-changing therapies for people living with rare diseases, particularly those related to rare kidney and metabolic disorders. The company has a strong focus on advancing science in these fields, with a pipeline that includes treatments for conditions such as IgA nephropathy and focal segmental glomerulosclerosis. With the full U. S. FDA approval of its non-immunosuppressive treatment for IgA nephropathy, Travere Therapeutics continues to set new standards of care. The company collaborates with the rare kidney disease community, including patient advocacy organizations and clinical trial investigators, to bring hope to patients with these serious conditions.
• provides portfolio-level strategic leadership and governance for Travere's scientific communications function • ensuring publications, medical education, congress planning, and scientific content are aligned to advancing Global Medical Affairs • sets the multi-year scientific communications plan • builds scalable infrastructure to support current and future pipeline assets • leads the strategy and integration of scientific communications across publications, medical education, and congress planning
• PharmD, PhD or MD in a related life sciences discipline • 12+ years’ experience within a scientific communications or medical affairs function • demonstrable portfolio-level leadership spanning multiple assets, preferably in rare diseases or nephrology • breadth of experience across publications, medical education, and congress strategy
• premium health • financial • work-life and well-being offerings for eligible employees and dependents • wellness and employee support programs • life insurance • disability • retirement plans with employer match • generous paid time off
Apply Now🕒 April 3
Director of Medical Communications leading global medical publications and congress strategy at Immatics. Focused on launch readiness for anzu-cel in cancer immunotherapy, driving impactful scientific narratives.
🕒 March 31
Chief Communications Officer leading internal and external communications strategies for Solar Mason. Responsible for enhancing the company's brand and managing crisis communications.
🕒 March 30
Vice President leading corporate and internal communications to enhance brand and employee engagement in a fast-growing biotech company focused on autoimmune diseases.
🕒 March 29
5001 - 10000
Director of Telecommunications providing strategic oversight for telecommunication systems across healthcare operations. Leading modernization and integration of communication tools for enhancing patient and member experiences.
🕒 January 31
Strategic Communications Specialist developing strategies for VA health program. Leading communication initiatives and overseeing various multimedia products to enhance patient experience.